	Effectiveness of Artificial Intelligence-Assisted Colposcopy in a Resource-Limited Population. Obstet Gynecol Surv Chang Y, Li T, Zhou Q, Kang D, Zhu L, Yang J, Kou Q, He H, Zhou Y, Liao Q, Du J, Yu X, Zhao Y. PMID: 41557929 [PubMed - indexed for MEDLINE]
	ESGO/INCIP Guidelines for the Management of Patients With Gynecological Cancers During Pregnancy. Obstet Gynecol Surv Amant F, Planchamp F, Berveiller P, Cardonick E, De Middelaer A, Fruscio R, Fumagalli M, Johansson ALV, Lambertini M, LeJeune CL, Lok C, McCluggage WG, Poortmans P, Sienko J, Hjortshøj CS, Swierczynska M, Testa AC, Van Assche IA, Van Calsteren K, Vincent V, Versteeg C, Zagouri F, Zapardiel Ignacio, Halaska MJ. PMID: 41557928 [PubMed - indexed for MEDLINE]
	Current Treatment for Symptomatic Uterine Fibroids: Available Evidence and Therapeutic Dilemmas. Obstet Gynecol Surv De Smit NS, de Lange ME, Boomsma MF, Huirnet JAF, Hehenkamp WJK. PMID: 41557923 [PubMed - indexed for MEDLINE]
	Validation and limitations of the distress thermometer in identifying depression among metastatic breast cancer patients in Nigeria: Methodological challenges in depression-specific screening validation. PLoS One Chavda T, Lawal A, Sowunmi A, Adegboyega B, Alabi A, Chung CC, Shirima S, Conserve DF, Bamodu OA. PMID: 41557711 [PubMed - indexed for MEDLINE]
	Zwitterionic molecularly imprinted polymers for selective capillary microextraction of N1,N12-Diacetylspermine (DiAcSpm) from breast cancer. PLoS One Ying K, Xue H, Du S, Wang X, Lei X. PMID: 41557635 [PubMed - indexed for MEDLINE]
	Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US. JAMA Netw Open Alagoz O, Lu Y, Gil Quessep E, Kerlikowske K, Mandelblatt JS, Sprague BL, Trentham-Dietz A, Hampton J, Groeneweg R, de Koning HJ, Miglioretti DL, Schechter CB, van Ravesteyn NT, Tosteson ANA, Stout NK, Lowry KP. PMID: 41557352 [PubMed - indexed for MEDLINE]
	Exosomal crosstalk between breast cancer cells and tumor-associated macrophages: mechanisms and therapeutic implications. Mol Biol Rep Gong RQ, Xu A, Huang X, Fu D. PMID: 41557096 [PubMed - in process]
	Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy. Breast Cancer Res Treat Pedersini R, Moretti L, Laganà M, Schivardi G, Baluta V, Zamparini M, Conforti E, Ravanelli M, Brentegani C, Amoroso V, Grisanti S, Buizza C, Scartabellati G, Bazzoli M, Ippolito G, Pellicioli F, Farina D, Berruti A, Cosentini D. PMID: 41557073 [PubMed - indexed for MEDLINE]
	Response to letter to the editor: Risk of endometrial cancer among breast cancer survivors in Japan-a matched cohort study. Breast Cancer Kawamura C, Iwagami M. PMID: 41557052 [PubMed - as supplied by publisher]
	Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study. Breast Cancer Res Treat Stabellini N, Kaur J, Owusu C, Moftakhar B, Mizukami T, de Oliveira SD, Montero AJ. PMID: 41557039 [PubMed - indexed for MEDLINE]
	Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. Breast Cancer Res Treat Alonso-Romero JL, Martínez-García J, Carrillo-Vicente R, Aramburo AF, Díez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jiménez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreño PR. PMID: 41557021 [PubMed - indexed for MEDLINE]
	Integrated multi-omics identifies MCRS1 as a causal hub linking aging, metabolic syndrome, and breast cancer progression. Int J Surg Tao Y, Ding X, Xuan W, Zhu H, Liu X, Chen Y, Wu J, Du J, Tian J, Qian G. PMID: 41556158 [PubMed - as supplied by publisher]
	Status of financial toxicity and its influence on quality of life in patients with gynecological malignancies in China. PeerJ Zhang L, Zhang Y, Chen S, Zhang J, Song M, Hu M, Liu L, Kong Y, Tang L, Wei W, Hong Z. PMID: 41556050 [PubMed - indexed for MEDLINE]
	Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Randomized, Phase II Study. MedComm (2020) Huang J, Wang H, Tong Y, Hong J, Zhu Y, Ren W, Yu J, Shi H, Gao W, Zhu S, Wu J, Huang O, Li J, He J, Chen W, Li Y, Shen K, Chen X. PMID: 41556040 [PubMed]
	Potential Targets and Biomarkers of Radionuclide Therapy in Breast Cancer. Cancer Innov Tan Y, Zeng C, Wang J, Ma F. PMID: 41555955 [PubMed]
	Opioids in breast cancer: Between analgesia and modulation of tumour progression. Br J Pharmacol Ciwun M, Tankiewicz-Kwedlo A, Pawlak D. PMID: 41555671 [PubMed - as supplied by publisher]
	Additive value of whole abdomen FDG PET/MRI to standard whole body PET/CT for detection of peritoneal recurrence of ovarian cancer. J Ovarian Res Baltacioglu MH, Soydal C, Araz M, Kuru Oz D, Taskin S, Kucuk NO, Erden GA, Elhan AH. PMID: 41555378 [PubMed - as supplied by publisher]
	Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy in breast cancer: a systematic review and meta-analysis with focus on triple-negative subtype and immune-related adverse events. BMC Cancer Aikelaimu A, Li W, Kaicaier M, Liu S, Zhang Y, Hou X, Wang Y, Ma L, Jiang W. PMID: 41555292 [PubMed - as supplied by publisher]
	Concomitant low-grade B-cell lymphoma and cervical intraepithelial neoplasia. BMJ Case Rep Wong Siaw Lin C, Ghosh A, Bhardwaj N, Zouridis A, Hellner K. PMID: 41554614 [PubMed - indexed for MEDLINE]
	The impact of prescribed versus achieved resistance training intensity on strength, body composition, and psychological health in women survivors of breast cancer: Protocol for the EFICAN 2.0 randomized trial. Contemp Clin Trials Esteban-Simón A, Díez-Fernández DM, Baena-Raya A, Pérez-Castilla A, Rodriguez-Solana A, Teodoro MR, Pérez-Romero A, Rodríguez-Pérez MA, Soriano-Maldonado A. PMID: 41554334 [PubMed - as supplied by publisher]

Articles 1 - 20 / 323230

Page 1 of 16162



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy